BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30567349)

  • 21. The Capsid Protein of Hepatitis E Virus Inhibits Interferon Induction via Its N-terminal Arginine-Rich Motif.
    Lin S; Yang Y; Nan Y; Ma Z; Yang L; Zhang YJ
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31717991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2.
    Stuart JH; Sumner RP; Lu Y; Snowden JS; Smith GL
    PLoS Pathog; 2016 Dec; 12(12):e1005955. PubMed ID: 27907166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis E Virus Methyltransferase Inhibits Type I Interferon Induction by Targeting RIG-I.
    Kang S; Choi C; Choi I; Han KN; Rho SW; Choi J; Kwon J; Park MK; Kim SJ; Myoung J
    J Microbiol Biotechnol; 2018 Sep; 28(9):1554-1562. PubMed ID: 30199924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-Dependent Inhibition of Melanoma Differentiation-Associated Gene 5-Mediated Activation of Type I Interferon Responses by Methyltransferase of Hepatitis E Virus.
    Myoung J; Min K
    J Microbiol Biotechnol; 2019 Jul; 29(7):1137-1143. PubMed ID: 31216792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis E Virus Papain-Like Cysteine Protease Inhibits Type I Interferon Induction by Down-Regulating Melanoma Differentiation-Associated Gene 5.
    Kim E; Myoung J
    J Microbiol Biotechnol; 2018 Nov; 28(11):1908-1915. PubMed ID: 30304915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progesterone-Mediated Enhancement of Hepatitis E Virus Replication in Human Liver Cells.
    Sooryanarain H; Ahmed SA; Meng XJ
    mBio; 2021 Jun; 12(3):e0143421. PubMed ID: 34154410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the hepatitis E virus ORF1.
    Ropp SL; Tam AW; Beames B; Purdy M; Frey TK
    Arch Virol; 2000; 145(7):1321-37. PubMed ID: 10963340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection.
    Zhou X; Xu L; Wang W; Watashi K; Wang Y; Sprengers D; de Ruiter PE; van der Laan LJ; Metselaar HJ; Kamar N; Peppelenbosch MP; Pan Q
    J Viral Hepat; 2016 Apr; 23(4):294-304. PubMed ID: 26620360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response.
    Wang W; Wang Y; Qu C; Wang S; Zhou J; Cao W; Xu L; Ma B; Hakim MS; Yin Y; Li T; Peppelenbosch MP; Zhao J; Pan Q
    Hepatology; 2018 Jun; 67(6):2096-2112. PubMed ID: 29194722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
    Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
    J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
    Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
    Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1).
    Ansari IH; Nanda SK; Durgapal H; Agrawal S; Mohanty SK; Gupta D; Jameel S; Panda SK
    J Med Virol; 2000 Mar; 60(3):275-83. PubMed ID: 10630959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms.
    Kang S; Myoung J
    J Microbiol Biotechnol; 2017 Oct; 27(10):1727-1735. PubMed ID: 29017236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural aspects of hepatitis E virus.
    Cancela F; Noceti O; Arbiza J; Mirazo S
    Arch Virol; 2022 Dec; 167(12):2457-2481. PubMed ID: 36098802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis E virus persists in the presence of a type III interferon response.
    Yin X; Li X; Ambardekar C; Hu Z; Lhomme S; Feng Z
    PLoS Pathog; 2017 May; 13(5):e1006417. PubMed ID: 28558073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bluetongue virus non-structural protein 3 (NS3) and NS4 coordinatively antagonize type Ⅰ interferon signaling by targeting STAT1.
    Li Z; Lu D; Yang H; Li Z; Zhu P; Xie J; Liao D; Zheng Y; Li H
    Vet Microbiol; 2021 Mar; 254():108986. PubMed ID: 33486325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease.
    Karpe YA; Lole KS
    J Gen Virol; 2011 Sep; 92(Pt 9):2088-2092. PubMed ID: 21653754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hepatitis E virus nonstructural polyprotein.
    Parvez MK
    Future Microbiol; 2017 Aug; 12():915-924. PubMed ID: 28686042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses.
    Koonin EV; Gorbalenya AE; Purdy MA; Rozanov MN; Reyes GR; Bradley DW
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8259-63. PubMed ID: 1518855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.